The answer is, of course, NO!
As the rush to appear to be doing something forced the governments of the world to embrace a new alien medical technology we now get to reap the consequences.
Why Weren’t These Vaccines Put Through the Proper Safety Trials For Gene Technology, Asks a Former Pharmaceutical Research ScientistDr. John D. Flack
HART member Dr John Flack, is a retired Director of Safety Evaluation at Beecham Pharmaceuticals and Senior Vice-president for Drug Discovery at SmithKline Beecham. These excerpts are from an article posted on the UK website The Daily Skeptic . They are terrifying.
…we come to December 2020, when, under emergency measures, ‘vaccines’ still in the experimental phase of development were rolled out with much fanfare to immunise the vulnerable population against the new viral disease of COVID-19. The disease, caused by a coronavirus named SARS-CoV-2, had and was still wreaking havoc across the globe – originating in China in late 2019. So, in a matter of weeks and months rather than years and decades, a new drug was being administered to healthy – albeit elderly and or infirm – human beings, to protect (immunise) them should they ever become infected with the virus. If this was something of a surprise, there was also the knowledge that previous attempts to discover effective and safe vaccines against earlier strains of this type of virus, namely SARS-1 and MERS, had failed. Furthermore, historically, coronaviruses in general had not proven to be amenable to conventional vaccine technology.
What then was the explanation for this amazing breakthrough at just the very time it was needed? And it was needed big-time, because an unprecedented strategy of locking up the whole population had been taken by public health and governments all around the world, rather surprisingly, all at about the same time, to deal with the pandemic. The only way out was to vaccinate the whole population – not just the old and infirm as we were first told – with a vaccine that was going to be – had to be – very safe and effective. The answer to their prayers was gene technology. Mention gene technology in former times in connection with growing crops more efficiently and eating the food derived from these crops you would have received a bloody nose from the natural food activists. Why not now? Were we told? Were we asleep? Were we all in awe of the hyperbole of Boris et al surrounding the brilliance of British – notably Oxford University – research? Just let’s call it a vaccine – everyone knows how safe they are. Conflating brand new and untried technology with safe and reliable traditional concepts – no problem!
But there is a problem. The old concepts of dead or attenuated viruses as vaccines – classical vaccine technology – we have had decades of experience both in their biology and manufacture. Annually the general population are offered ‘flu vaccines – few are concerned about their safety, and rightly. Not too much concern either as to their efficacy, but who cares if they are safe. Surely these new ‘vaccines’ can be considered in a similar manner? No, I am afraid not. These new gene-based ‘vaccines’ are working in a completely novel way – nothing remotely resembling that of traditional vaccines. Given that pharmaceutical companies work competitively it was also somewhat of a surprise they took the same approach of targeting what has been termed the ‘spike protein’ of the SARS-CoV-2 virus. This protein is nasty – sometimes being referred to as a ‘pathogenic protein’ – and is recognised as causing many of the awful pathologies associated with the disease of COVID-19. Logically you would inactivate or at least attenuate this nasty spike protein and develop a vaccine around the attenuated virus. But that’s not what was done. These ‘vaccines’ do not contain any of the offending virus at all but rather the gene sequence that causes the nasty spike protein to be made in the body. We have little idea how much of this nasty protein is produced or for how long it lasts after an injection of the gene sequence. Furthermore, stimulating the body’s own complex biological systems to produce the spike protein will mean that the amount of protein produced will vary from person to person. The idea is that the spike protein produced by the gene encoding it elicits a response by our immune system to produce antibodies directed against the spike. When the wild virus comes along and infects us the antibodies recognise the spike protein and attack it thus preventing its nasty effects. And it does, though as we have since learnt this approach isn’t very good at preventing infection or stopping its transmission. Are we perhaps clutching at straws too in claiming that these ‘vaccines’ are preventing serious disease and death? Have we not learnt anything over the past two years in treating Covid symptoms with conventional therapeutic drugs? It is now known the beneficial effects on antibody production wane after a few weeks and months and there is a need for booster injections – how many per annum? Consequently, they surely cannot be anything like the scientific and medical success that is being claimed by the politicians and the mainstream media. A fantastic rollout maybe, but of a second-rate ‘vaccine’. Back to the drawing board chaps. The Pfizer CEO promises a new ‘vaccine’ tackling the Omicron variant in March. Sounds good but too late and pointless…
…“There is the possibility that this new class of medicines were classed by the regulatory authorities as conventional vaccines and didn’t undergo the preclinical testing (such as described above) required of new chemical entities. If so, this can only be classed as a huge error of judgement by the Government regulators. I can quite appreciate any legal challenge being made against them. Considering the precautionary principle that has characterised Government actions regarding non- pharmaceutical interventions, the contrast to their approach to this new gene technology is striking. At best, it might be characterised as cavalier, but more bluntly the phrase ‘fast and loose’ comes to mind. But of course, Governments were in a very deep hole and one growing deeper as they doubled-down on the precautionary principles of non-pharmaceutical interventions.
Nothing now could be allowed to detract from the narrative of the brilliance of the British scientists in discovering these new medicines, nor the huge accolades heaped on the NHS and the Government for the logistics of rolling them out.
But it must be recognised as being a huge gamble. Unfortunately, we will never know whether it is a gamble that has paid off. Considering what we know about the life-cycle of viruses generally and their well-established properties of greater contagion but weakening of their virulency over time as they mutate, it’s not clear to me how much of a real benefit these novel ‘vaccines’ have been.
The clinical Phase 3 studies which began as randomised controlled trials have now been unblinded – there is now no control/placebo group. There will be no way of knowing from empirical data whether these ‘vaccines’ have been effective when the trials complete in 2023. And then again there seems to be no consideration being given to the collateral damage caused by the non-pharmaceutical or the side-effects caused by the ‘vaccines’. It’s not difficult to claim success when one chooses to consider just one side of the equation.”